TFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer
Felicity E. B. May(Newcastle University), Bruce R. Westley(Newcastle University)
Cited by 56
Related Papers
Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancer
|Cancer Management and Research|2014|83
Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway
|Molecular Cancer|2016|55
Insulin and the insulin receptor collaborate to promote human gastric cancer
|Gastric Cancer|2021|22
Increased expression of both insulin receptor substrates 1 and 2 confers increased sensitivity to IGF-1 stimulated cell migration
|Endocrine Related Cancer|2009|20